Short-term mortality risk in children and young adults with type 1 diabetes: The population-based Registry of the Province of Turin, Italy

2009 ◽  
Vol 19 (5) ◽  
pp. 340-344 ◽  
Author(s):  
G. Bruno ◽  
F. Cerutti ◽  
F. Merletti ◽  
G. Novelli ◽  
F. Panero ◽  
...  
Diabetologia ◽  
2005 ◽  
Vol 48 (6) ◽  
pp. 1114-1117 ◽  
Author(s):  
G. G. Dahlquist ◽  
A. Pundziūtė-Lyckå ◽  
L. Nyström ◽  

Author(s):  
Sascha René Tittel ◽  
◽  
Désirée Dunstheimer ◽  
Dörte Hilgard ◽  
Burkhild Knauth ◽  
...  

Abstract Aims To analyse the association between coeliac disease (CD) and depression in children, adolescents, and young adults with type 1 diabetes (T1D). Methods We included 79,067 T1D patients aged 6–20 years, with at least six months of diabetes duration, and treatment data between 1995 and 2019 were documented in the diabetes patient follow-up registry. We categorized patients into four groups: T1D only (n = 73,699), T1 + CD (n = 3379), T1D + depression (n = 1877), or T1D + CD + depression (n = 112). Results CD and depression were significantly associated (adjusted OR: 1.25 [1.03–1.53]). Females were more frequent in both the depression and the CD group compared with the T1D only group. Insulin pumps were used more frequently in T1D + CD and T1D + depression compared with T1D only (both p < .001). HbA1c was higher in T1D + depression (9.0% [8.9–9.0]), T1D + CD + depression (8.9% [8.6–9.2]), both compared with T1D only (8.2% [8.2–8.2], all p < .001). We found comorbid autism, attention deficit hyperactivity disorder, anxiety, schizophrenia, and eating disorders more frequently in the T1D + CD + depression group compared with T1D only (all p < .001). Conclusions CD and depression are associated in young T1D patients. The double load of T1D and CD may lead to an increased risk for depression. Depression was associated with additional psychological and neurological comorbidities. Aside from imperative CD screening after T1D diagnosis and regular intervals, depression screening might be helpful in routine care, especially in patients with diagnosed CD.


Diabetes Care ◽  
2003 ◽  
Vol 26 (2) ◽  
pp. 333-337 ◽  
Author(s):  
A. P. Lambert ◽  
S. Ellard ◽  
L. I.S. Allen ◽  
I. W. Gallen ◽  
K. M. Gillespie ◽  
...  

PLoS ONE ◽  
2014 ◽  
Vol 9 (2) ◽  
pp. e87408 ◽  
Author(s):  
Soulmaz Fazeli Farsani ◽  
Patrick C. Souverein ◽  
Marja M. J. van der Vorst ◽  
Aukje K. Mantel-Teeuwisse ◽  
Catherijne A. J. Knibbe ◽  
...  

2018 ◽  
Vol 20 (8) ◽  
pp. 1965-1971 ◽  
Author(s):  
Andrew Collier ◽  
Paul J. Connelly ◽  
Mario Hair ◽  
Lyall Cameron ◽  
Sujoy Ghosh ◽  
...  

BMJ Open ◽  
2021 ◽  
Vol 11 (11) ◽  
pp. e049087
Author(s):  
Matthew James Smith ◽  
Edmund Njeru Njagi ◽  
Aurelien Belot ◽  
Clémence Leyrat ◽  
Audrey Bonaventure ◽  
...  

ObjectivesWe aimed to assess the association between multimorbidity and deprivation on short-term mortality among patients with diffuse large B-cell (DLBCL) and follicular lymphoma (FL) in England.SettingThe association of multimorbidity and socioeconomic deprivation on survival among patients diagnosed with DLBCL and FL in England between 2005 and 2013. We linked the English population-based cancer registry with electronic health records databases and estimated adjusted mortality rate ratios by multimorbidity and deprivation status. Using flexible hazard-based regression models, we computed DLBCL and FL standardised mortality risk by deprivation and multimorbidity at 1 year.ResultsOverall, 41 422 patients aged 45–99 years were diagnosed with DLBCL or FL in England during 2005–2015. Most deprived patients with FL with multimorbidities had three times higher hazard of 1-year mortality (HR: 3.3, CI 2.48 to 4.28, p<0.001) than least deprived patients without comorbidity; among DLBCL, there was approximately twice the hazard (HR: 1.9, CI 1.70 to 2.07, p<0.001).ConclusionsMultimorbidity, deprivation and their combination are strong and independent predictors of an increased short-term mortality risk among patients with DLBCL and FL in England. Public health measures targeting the reduction of multimorbidity among most deprived patients with DLBCL and FL are needed to reduce the short-term mortality gap.


Sign in / Sign up

Export Citation Format

Share Document